Bruk Getachew, Ph.D. - Publications

Affiliations: 
2007 Howard University 
Area:
Neuroscience Biology, Pharmacology

54 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Fortuna V, Lima J, Oliveira GF, Oliveira YS, Getachew B, Nekhai S, Aschner M, Tizabi Y. Ferroptosis as an emerging target in sickle cell disease. Current Research in Toxicology. 7: 100181. PMID 39021403 DOI: 10.1016/j.crtox.2024.100181  0.489
2024 Tizabi Y, Bennani S, El Kouhen N, Getachew B, Aschner M. Heavy Metal Interactions with Neuroglia and Gut Microbiota: Implications for Huntington's Disease. Cells. 13. PMID 38994995 DOI: 10.3390/cells13131144  0.509
2024 Tizabi Y, Getachew B, Hauser SR, Tsytsarev V, Manhães AC, da Silva VDA. Role of Glial Cells in Neuronal Function, Mood Disorders, and Drug Addiction. Brain Sciences. 14. PMID 38928557 DOI: 10.3390/brainsci14060558  0.702
2024 Carvalho FV, Landis HE, Getachew B, Silva VDA, Ribeiro PR, Aschner M, Tizabi Y. Iron toxicity, ferroptosis and microbiota in Parkinson's disease: Implications for novel targets. Advances in Neurotoxicology. 11: 105-132. PMID 38770370 DOI: 10.1016/bs.ant.2024.02.001  0.491
2024 Csoka AB, El Kouhen N, Bennani S, Getachew B, Aschner M, Tizabi Y. Roles of Epigenetics and Glial Cells in Drug-Induced Autism Spectrum Disorder. Biomolecules. 14. PMID 38672454 DOI: 10.3390/biom14040437  0.507
2024 Soares ÉN, Costa ACDS, Ferrolho GJ, Ureshino RP, Getachew B, Costa SL, da Silva VDA, Tizabi Y. Nicotinic Acetylcholine Receptors in Glial Cells as Molecular Target for Parkinson's Disease. Cells. 13. PMID 38534318 DOI: 10.3390/cells13060474  0.544
2024 Getachew B, Hauser SR, Bennani S, El Kouhen N, Sari Y, Tizabi Y. Adolescent alcohol drinking interaction with the gut microbiome: implications for adult alcohol use disorder. Advances in Drug and Alcohol Research. 4. PMID 38322648 DOI: 10.3389/adar.2024.11881  0.756
2023 Tizabi Y, Getachew B, Aschner M. Butyrate Protects and Synergizes with Nicotine against Iron- and Manganese-induced Toxicities in Cell Culture. Neurotoxicity Research. 42: 3. PMID 38095760 DOI: 10.1007/s12640-023-00682-z  0.554
2023 Tizabi Y, Bennani S, El Kouhen N, Getachew B, Aschner M. Interaction of Heavy Metal Lead with Gut Microbiota: Implications for Autism Spectrum Disorder. Biomolecules. 13. PMID 37892231 DOI: 10.3390/biom13101549  0.508
2023 Tizabi Y, Getachew B, Aschner M. Butyrate protects and synergizes with nicotine against iron- and manganese-induced toxicities in cell culture: Implications for neurodegenerative diseases. Research Square. PMID 37886507 DOI: 10.21203/rs.3.rs-3389904/v1  0.556
2023 Alhazzaa RA, McKinley RE, Getachew B, Tizabi Y, Heinbockel T, Csoka AB. Epigenetic Changes Induced by High Glucose in Human Pancreatic Beta Cells. Journal of Diabetes Research. 2023: 9947294. PMID 36815184 DOI: 10.1155/2023/9947294  0.465
2022 Getachew B, Csoka AB, Copeland RL, Manaye KF, Tizabi Y. Dihydromyricetin Protects Against Salsolinol-Induced Toxicity in Dopaminergic Cell Line: Implication for Parkinson's Disease. Neurotoxicity Research. PMID 36585544 DOI: 10.1007/s12640-022-00631-2  0.528
2022 Getachew B, Landis HE, Manaye KF, Tizabi Y. COVID-19-Associated Coagulopathy: Role of Vitamins D and K. Current Pharmaceutical Biotechnology. PMID 35638271 DOI: 10.2174/1389201023666220527110455  0.457
2022 Getachew B, Csoka AB, Tizabi Y. Dihydromyricetin Protects Against Ethanol-Induced Toxicity in SH-SY5Y Cell Line: Role of GABA Receptor. Neurotoxicity Research. 40: 892-899. PMID 35386023 DOI: 10.1007/s12640-022-00503-9  0.581
2021 Landis HE, Getachew B, Tizabi Y. Therapeutic Potential of Flavonoids and Zinc in COVID-19. Nutrition Today. 1. PMID 35340665  0.495
2021 Getachew B, Csoka AB, Garden AR, Copeland RL, Tizabi Y. Sodium Butyrate Protects Against Ethanol-Induced Toxicity in SH-SY5Y Cell Line. Neurotoxicity Research. PMID 34554410 DOI: 10.1007/s12640-021-00418-x  0.651
2021 Tizabi Y, Getachew B, Aschner M. Novel Pharmacotherapies in Parkinson's Disease. Neurotoxicity Research. PMID 34003454 DOI: 10.1007/s12640-021-00375-5  0.54
2021 Getachew B, Tizabi Y. Vitamin D and COVID-19: Role of ACE2, age, gender, and ethnicity. Journal of Medical Virology. PMID 33990955 DOI: 10.1002/jmv.27075  0.469
2020 Tizabi Y, Getachew B, Copeland RL, Aschner M. Nicotine and the nicotinic cholinergic system in COVID-19. The Febs Journal. PMID 32790936 DOI: 10.1111/Febs.15521  0.606
2020 Getachew B, Csoka AB, Bhatti A, Copeland RL, Tizabi Y. Butyrate Protects Against Salsolinol-Induced Toxicity in SH-SY5Y Cells: Implication for Parkinson's Disease. Neurotoxicity Research. PMID 32572814 DOI: 10.1007/S12640-020-00238-5  0.577
2019 Getachew B, Tizabi Y. Effects of C-Terminal Domain of the Heavy Chain of Tetanus Toxin on Gut Microbiota in a Rat Model of Depression. Clinical Pharmacology and Translational Medicine. 3: 152-159. PMID 32159077  0.552
2019 Tizabi Y, Getachew B, Csoka AB, Manaye KF, Copeland RL. Novel targets for parkinsonism-depression comorbidity. Progress in Molecular Biology and Translational Science. 167: 1-24. PMID 31601399 DOI: 10.1016/Bs.Pmbts.2019.06.004  0.573
2019 Getachew B, Tizabi Y. Antidepressant Effects of Moxidectin, an Antiparasitic Drug, in a Rat Model of Depression. Behavioural Brain Research. 112220. PMID 31513828 DOI: 10.1016/J.Bbr.2019.112220  0.611
2019 Getachew B, Reyes RE, Davies DL, Tizabi Y. Moxidectin Effects on Gut Microbiota of Wistar-Kyoto Rats: Relevance to Depressive-Like Behavior. Clinical Pharmacology and Translational Medicine. 3: 134-142. PMID 31321385  0.649
2019 Getachew B, Mendieta L, Csoka AB, Aguilera J, Tizabi Y. Antidepressant Effects of C-Terminal Domain of the Heavy Chain of Tetanus Toxin in a Rat Model of Depression. Behavioural Brain Research. 111968. PMID 31125623 DOI: 10.1016/J.Bbr.2019.111968  0.606
2019 Getachew B, Tizabi Y. Both Ketamine and NBQX Attenuate Alcohol-Withdrawal Induced Depression in Male Rats. Journal of Drug and Alcohol Research. 8. PMID 31032138 DOI: 10.4303/jdar/236069  0.684
2019 Reglodi D, Toth D, Vicena V, Manavalan S, Brown D, Getachew B, Tizabi Y. Therapeutic potential of PACAP in alcohol toxicity. Neurochemistry International. PMID 30682380 DOI: 10.1016/J.Neuint.2019.01.017  0.791
2018 Getachew B, Aubee JI, Schottenfeld RS, Csoka AB, Thompson KM, Tizabi Y. Ketamine interactions with gut-microbiota in rats: relevance to its antidepressant and anti-inflammatory properties. Bmc Microbiology. 18: 222. PMID 30579332 DOI: 10.1186/S12866-018-1373-7  0.602
2018 Getachew B, Csoka AB, Aschner M, Tizabi Y. Nicotine protects against manganese and iron-induced toxicity in SH-SY5Y cells: Implication for Parkinson's disease. Neurochemistry International. 124: 19-24. PMID 30557592 DOI: 10.1016/J.Neuint.2018.12.003  0.607
2018 Kanherkar RR, Getachew B, Ben-Sheetrit J, Varma S, Heinbockel T, Tizabi Y, Csoka AB. The Effect of Citalopram on Genome-Wide DNA Methylation of Human Cells. International Journal of Genomics. 2018: 8929057. PMID 30148158 DOI: 10.1155/2018/8929057  0.535
2018 Deehan GA, Hauser SR, Getachew B, Aaron Waeiss R, Engleman EA, Knight CP, McBride WJ, Truitt WA, Bell RL, Rodd ZA. Selective breeding for high alcohol consumption and response to nicotine: locomotor activity, dopaminergic in the mesolimbic system, and innate genetic differences in male and female alcohol-preferring, non-preferring, and replicate lines of high-alcohol drinking and low-alcohol drinking rats. Psychopharmacology. PMID 30043172 DOI: 10.1007/S00213-018-4970-0  0.744
2018 Getachew B, Hudson T, Heinbockel T, Csoka AB, Tizabi Y. Protective Effects of Donepezil Against Alcohol-Induced Toxicity in Cell Culture: Role of Caspase-3. Neurotoxicity Research. PMID 29804239 DOI: 10.1007/S12640-018-9913-3  0.643
2018 Rezvani AH, Tizabi Y, Slade S, Getachew B, Levin ED. Sub-anesthetic Doses of Ketamine Attenuate Nicotine Self-administration in Rats. Neuroscience Letters. PMID 29339170 DOI: 10.1016/J.Neulet.2018.01.022  0.626
2018 Tizabi Y, Getachew B, Ferguson CL, Csoka AB, Thompson KM, Gomez-Paz A, Ruda-Kucerova J, Taylor RE. Low Vs. High Alcohol: Central Benefits Vs. Detriments. Neurotoxicity Research. PMID 29302849 DOI: 10.1007/S12640-017-9859-X  0.684
2018 Kanherkar RR, Getachew B, Ben-Sheetrit J, Verma S, Heinbockel T, Tizabi Y, Csoka AB. The effect of citalopram on genome-wide DNA methylation of human cells International Journal of Genomics. 2018: Article ID 8929057,. DOI: 10.1155/2018/8929057  0.452
2017 Tizabi Y, Getachew B. Nicotinic Receptor Intervention in Parkinson's Disease: Future Directions. Clinical Pharmacology and Translational Medicine. 1: 14-19. PMID 29863173  0.558
2017 Kalejaiye O, Getachew B, Ferguson CL, Taylor RE, Tizabi Y. Alcohol-Induced Increases in Inflammatory Cytokines Are Attenuated by Nicotine in Region-Selective Manner in Male Rats. Journal of Drug and Alcohol Research. 6. PMID 29416901 DOI: 10.4303/jdar/236036  0.815
2017 Rezvani AH, Levin ED, Cauley M, Getachew B, Tizabi Y. Ketamine Differentially Attenuates Alcohol Intake in Male Versus Female Alcohol Preferring (P) Rats. Journal of Drug and Alcohol Research. 6. PMID 29416900 DOI: 10.4303/jdar/236030  0.652
2017 Ruda-Kucerova J, Babinska Z, Luptak M, Getachew B, Tizabi Y. Both ketamine and NBQX attenuate alcohol drinking in male Wistar rats. Neuroscience Letters. PMID 29288725 DOI: 10.1016/J.Neulet.2017.12.055  0.702
2017 Getachew B, Hauser SR, Csoka AB, Taylor RE, Tizabi Y. Role of cortical alpha-2 adrenoceptors in alcohol withdrawal-induced depression and tricyclic antidepressants. Drug and Alcohol Dependence. 175: 133-139. PMID 28414989 DOI: 10.1016/J.Drugalcdep.2017.03.004  0.771
2017 Manavalan S, Getachew B, Manaye KF, Khundmiri SJ, Csoka AB, McKinley R, Tamas A, Reglodi D, Tizabi Y. PACAP Protects Against Ethanol and Nicotine Toxicity in SH-SY5Y Cells: Implications for Drinking-Smoking Co-morbidity. Neurotoxicity Research. PMID 28342135 DOI: 10.1007/S12640-017-9727-8  0.693
2012 Hauser SR, Getachew B, Oster SM, Dhaher R, Ding ZM, Bell RL, McBride WJ, Rodd ZA. Nicotine modulates alcohol-seeking and relapse by alcohol-preferring (P) rats in a time-dependent manner. Alcoholism, Clinical and Experimental Research. 36: 43-54. PMID 21689122 DOI: 10.1111/J.1530-0277.2011.01579.X  0.744
2011 Hauser SR, Getachew B, Taylor RE, Tizabi Y. Alcohol induced depressive-like behavior is associated with a reduction in hippocampal BDNF. Pharmacology, Biochemistry, and Behavior. 100: 253-8. PMID 21930150 DOI: 10.1016/J.Pbb.2011.08.014  0.797
2011 Hauser SR, Ding ZM, Getachew B, Toalston JE, Oster SM, McBride WJ, Rodd ZA. The posterior ventral tegmental area mediates alcohol-seeking behavior in alcohol-preferring rats. The Journal of Pharmacology and Experimental Therapeutics. 336: 857-65. PMID 21148248 DOI: 10.1124/Jpet.110.168260  0.698
2011 Getachew B, Hauser SR, Dhaher R, Katner SN, Bell RL, Oster SM, McBride WJ, Rodd ZA. CB1 receptors regulate alcohol-seeking behavior and alcohol self-administration of alcohol-preferring (P) rats. Pharmacology, Biochemistry, and Behavior. 97: 669-75. PMID 21110997 DOI: 10.1016/J.Pbb.2010.11.006  0.711
2010 Dhaher R, Hauser SR, Getachew B, Bell RL, McBride WJ, McKinzie DL, Rodd ZA. The Orexin-1 Receptor Antagonist SB-334867 Reduces Alcohol Relapse Drinking, but not Alcohol-Seeking, in Alcohol-Preferring (P) Rats. Journal of Addiction Medicine. 4: 153-9. PMID 20871792 DOI: 10.1097/Adm.0B013E3181Bd893F  0.747
2010 Getachew B, Hauser SR, Taylor RE, Tizabi Y. Alcohol-induced depressive-like behavior is associated with cortical norepinephrine reduction. Pharmacology, Biochemistry, and Behavior. 96: 395-401. PMID 20600245 DOI: 10.1016/J.Pbb.2010.06.011  0.798
2010 Tizabi Y, Hauser SR, Tyler KY, Getachew B, Madani R, Sharma Y, Manaye KF. Effects of nicotine on depressive-like behavior and hippocampal volume of female WKY rats. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 34: 62-9. PMID 19800382 DOI: 10.1016/J.Pnpbp.2009.09.024  0.757
2009 Tizabi Y, Getachew B, Rezvani AH, Hauser SR, Overstreet DH. Antidepressant-like effects of nicotine and reduced nicotinic receptor binding in the Fawn-Hooded rat, an animal model of co-morbid depression and alcoholism. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 33: 398-402. PMID 18835320 DOI: 10.1016/J.Pnpbp.2008.09.010  0.798
2008 Getachew B, Hauser SR, Taylor RE, Tizabi Y. Desipramine blocks alcohol-induced anxiety- and depressive-like behaviors in two rat strains. Pharmacology, Biochemistry, and Behavior. 91: 97-103. PMID 18640149 DOI: 10.1016/J.Pbb.2008.06.016  0.795
2008 Rezvani AH, Tizabi Y, Getachew B, Hauser SR, Caldwell DP, Hunter C, Levin ED. Chronic nicotine and dizocilpine effects on nicotinic and NMDA glutamatergic receptor regulation: interactions with clozapine actions and attentional performance in rats. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 32: 1030-40. PMID 18343006 DOI: 10.1016/J.Pnpbp.2008.01.018  0.743
2007 Getachew B, Hauser SR, Taylor RE, Tizabi Y. Antidepressants Block Depressive‐Like Behavior Following Alcohol Withdrawal In Rats: Implication For Relapse The Faseb Journal. 21. DOI: 10.1096/Fasebj.21.5.A413-B  0.784
2005 Levin ED, Tizabi Y, Rezvani AH, Caldwell DP, Petro A, Getachew B. Chronic nicotine and dizocilpine effects on regionally specific nicotinic and NMDA glutamate receptor binding. Brain Research. 1041: 132-42. PMID 15829222 DOI: 10.1016/J.Brainres.2005.01.104  0.606
2001 Tizabi Y, Getachew B, Davila-Garcia M, Taylor RE. Alcohol preference: association with reduced striatal nicotinic receptors. Alcohol and Alcoholism (Oxford, Oxfordshire). 36: 318-22. PMID 11468132 DOI: 10.1093/Alcalc/36.4.318  0.679
Show low-probability matches.